Navigation Links
Signostics Receives FDA Clearance for World's Smallest Ultrasound Product

PALO ALTO, Calif., May 19 /PRNewswire/ -- Pioneering medical device company Signostics announced today it has secured clearance from the U.S. Food and Drug Administration (FDA) for its palm-sized personal ultrasound device, the 'Signos'.


Signostics has developed a cost-effective device that for the first time makes it affordable for individual health professionals to use ultrasound in their clinical practice. Just as handheld devices transformed the business world, it is anticipated the Signos will change the way healthcare professionals practice medicine.

Retailing at a fraction of the cost of larger machines, the Signos is the world's smallest and lightest ultrasound device. With a weight of approximately half a pound, its portability and low price point appeals to a large range of medical markets, including emergency medicine, primary care, remote healthcare, critical care, pediatrics, musculo-skeletal, palliative care and sports medicine. This breakthrough product is the first ultrasound platform technology that clinicians can place in their pocket or wear around their neck like a stethoscope.

The device delivers high-resolution images anywhere, at any time for general medical applications, including: abdominal assessments such as bladder, abdominal aortic aneurysm screening, and trauma assessment; musculoskeletal; and basic obstetrics, such as pregnancy viability and fetal positioning.

According to McGregorTan Research in their 2005 Market Assessment, the global personal ultrasound market is estimated to be worth around $3 billion, with the U.S. market worth about $1 billion.

"Securing FDA clearance is a huge milestone for our company," Dr. Bartlett said. "The global financial crisis over the last six months has put pressure on health costs around the world, with a need for more affordable medical devices that can deliver results rapidly and conveniently. The 'Signos' meets the requirement."

"The level of physician interest in the Signos at industry events and amongst industry leaders has been remarkable, and we are very optimistic about the sales outlook for the company."

Signostics has received funding from angel investors, Australian government grant providers and Playford Capital. The company will shortly close a round of funding at almost US$4 million, having raised a total of US$12 million to date.

The brainchild of physician-engineer Dr. Neil Bartlett, Signostics was established in Adelaide, Australia in January 2005. Signostics employs a cutting edge development team including physicians, sonographers as well as biomedical, electronic and software engineers. Signostics' global sales and marketing headquarters is located in the United States in Silicon Valley, California.

    For media inquiries contact:
    Corina Cooper, Marketing Communications
    Phone: 650.327.4000

SOURCE Signostics
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Nerviano Medical Sciences Receives Approval From the FDA to Enter Phase I Clinical Trials for Their Polo Like Kinase (PLK) Inhibitor
2. EFT BioTech Holdings, Inc.s Subsidiary Receives First Permit to Cross Taiwan Strait
3. Apex Bioventures Acquisition Corporation Receives Notice of Extension from NYSE Amex
4. DuPont Receives Canadian Regulatory Approval for High Oleic Soybean Trait
5. Sangamo BioSciences Receives $100,000 Grand Challenges Explorations Grant for Innovative Global Health Research
6. Amedica Receives CE Mark for Valeo(TM) Ceramic Spinal Implant System Incorporating CSC Technology
7. Divergence Receives $1.2 Million in Grants, Including NSF Grant to Fund Continuing Nematode Research in Corn
8. OncoGenex Receives Confirmation from FDA on the Design of a Second Phase 3 Trial Evaluating OGX-011 for the Treatment of Advanced Prostate Cancer
9. China Biologic Products Receives $5.3 Million Order from Largest Biopharmaceutical Distributor in India
10. China Medical Technologies Receives SFDA Approval for Its Bladder Cancer FISH Probe
11. Mach One BioPharm Process Operating Group Receives Contract From American Beef Processors
Post Your Comments:
(Date:6/24/2016)... ... June 24, 2016 , ... Researchers at the Universita ... miRNAs in people with peritoneal or pleural mesothelioma. Their findings are the subject of ... now. , Diagnostic biomarkers are signposts in the blood, lung fluid or tissue ...
(Date:6/23/2016)... /PRNewswire/ - FACIT has announced the creation of ... company, Propellon Therapeutics Inc. ("Propellon" or "the Company"), ... portfolio of first-in-class WDR5 inhibitors for the treatment ... represent an exciting class of therapies, possessing the ... cancer patients. Substantial advances have been achieved with ...
(Date:6/23/2016)... SANTA MONICA, Calif. , June 23, 2016  The Prostate Cancer ... to pioneer increasingly precise treatments and faster cures for prostate cancer. Members of ... 77 institutions across 15 countries. Read More About the ... ... ...
(Date:6/23/2016)... ... 23, 2016 , ... STACS DNA Inc., the sample tracking software company, today ... Laboratory, has joined STACS DNA as a Field Application Specialist. , “I am ... and COO of STACS DNA. “In further expanding our capacity as a scientific integrator, ...
Breaking Biology Technology:
(Date:5/16/2016)... --  EyeLock LLC , a market leader of iris-based ... IoT Center of Excellence in Austin, Texas ... embedded iris biometric applications. EyeLock,s iris authentication ... with unmatched biometric accuracy, making it the most proven ... platform uses video technology to deliver a fast and ...
(Date:5/9/2016)... Elevay is currently known as ... for high net worth professionals seeking travel for work ... world, there is still no substitute for a face-to-face ... your deal with a firm handshake. This is why ... of citizenship via investment programs like those offered by ...
(Date:4/28/2016)... India , April 28, 2016 ... Infosys (NYSE: INFY ), and Samsung SDS, a ... that will provide end customers with a more secure, ... services.      (Logo: ) , ... services, but it also plays a fundamental part in enabling ...
Breaking Biology News(10 mins):